Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2011

Open Access 01-12-2011 | Study protocol

A randomised controlled trial linking mental health inpatients to community smoking cessation supports: A study protocol

Authors: Emily AL Stockings, Jennifer A Bowman, John Wiggers, Amanda L Baker, Margarett Terry, Richard Clancy, Paula M Wye, Jenny Knight, Lyndell H Moore

Published in: BMC Public Health | Issue 1/2011

Login to get access

Abstract

Background

Mental health inpatients smoke at higher rates than the general population and are disproportionately affected by tobacco dependence. Despite the advent of smoke free policies within mental health hospitals, limited systems are in place to support a cessation attempt post hospitalisation, and international evidence suggests that most smokers return to pre-admission smoking levels following discharge. This protocol describes a randomised controlled trial that will test the feasibility, acceptability and efficacy of linking inpatient smoking care with ongoing community cessation support for smokers with a mental illness.

Methods/Design

This study will be conducted as a randomised controlled trial. 200 smokers with an acute mental illness will be recruited from a large inpatient mental health facility. Participants will complete a baseline survey and will be randomised to either a multimodal smoking cessation intervention or provided with hospital smoking care only. Randomisation will be stratified by diagnosis (psychotic, non-psychotic). Intervention participants will be provided with a brief motivational interview in the inpatient setting and options of ongoing smoking cessation support post discharge: nicotine replacement therapy (NRT); referral to Quitline; smoking cessation groups; and fortnightly telephone support. Outcome data, including cigarettes smoked per day, quit attempts, and self-reported 7-day point prevalence abstinence (validated by exhaled carbon monoxide), will be collected via blind interview at one week, two months, four months and six months post discharge. Process information will also be collected, including the use of cessation supports and cost of the intervention.

Discussion

This study will provide comprehensive data on the potential of an integrated, multimodal smoking cessation intervention for persons with an acute mental illness, linking inpatient with community cessation support.

Trial Registration

Australian and New Zealand Clinical Trials Registry ANZTCN: ACTRN12609000465​257
Appendix
Available only for authorised users
Literature
1.
Lawrence D, Mitrou F, Zubrick SR: Smoking and mental illness: results from population surveys in Australia and the United States. BMC Public Health. 2009, 9 (285): 1-14.
2.
Keizer I, Descloux V, Eytan A: Variations in smoking after admission to psychiatric inpatient units and impact of a partial smoking ban on smoking and on smoking-related perceptions. Int J Soc Psychiatr. 2009, 55 (2): 109-125. 10.1177/0020764008092357.CrossRef
3.
Lineberry TW, Allen JD, Nash J, Galardy CW: Population-based prevalence of smoking in psychiatric inpatients: a focus on acute suicide risk and major diagnostic groups. Compr Psychiat. 2009, 50: 526-532. 10.1016/j.comppsych.2009.01.004.CrossRefPubMedPubMedCentral
4.
Prochaska JJ, Fletcher L, Hall SE, Hall SM: Return to smoking following a smoke-free psychiatric hospitalization. Am J Addictions. 2006, 15: 15-22. 10.1080/10550490500419011.CrossRef
5.
Reichler HM, Baker AL, Lewin T, Carr VJ: Smoking among in-patients with drug-related problems in an Australian psychiatric hospital. Drug Alcohol Rev. 2001, 20: 231-237.CrossRef
6.
Australian Institute of Health and Welfare: National drug strategy household survey: detailed findings. 2007, Canberra: AIHW, 22:
7.
Young D, Wilson N, Borland R, Edwards R, Werasekera D: Prevalence, correlates of, and reasons for using roll-your-own tobacco in a high RYO use country: findings from the ITC New Zealand survey. Nicotine Tob Res. 2010, 12: 1089-1098. 10.1093/ntr/ntq155.CrossRefPubMed
8.
Diaz F, Rendon D, Velasquez D, Susce M, de Leon J: Datapoints: smoking and smoking cessation among persons with severe mental illnesses. Psychiat Serv. 2006, 57: 462-10.1176/appi.ps.57.4.462.CrossRef
9.
Hagman B, Delnevo C, Hrywna M, Williams J: Tobacco use among those with serious psychological distress: results from the national survey of drug use and health. Addictive Behav. 2008, 33: 582-592. 10.1016/j.addbeh.2007.11.007.CrossRef
10.
Moeller-Saxone K: Cigarette smoking and interest in quitting among consumers at a psychiatric disability rehabilitation and support service in Victoria. Aust NZ J Publ Heal. 2008, 32: 479-481. 10.1111/j.1753-6405.2008.00283.x.CrossRef
11.
Robson D, Gray R: Serious mental illness and physical health problems: A discussion paper. Int J Nurs Stud. 2007, 44: 457-466. 10.1016/j.ijnurstu.2006.07.013.CrossRefPubMed
12.
Tosh G, Clifton A, Bachner M: General physical health advice for people with serious mental illness (Review). Cochrane Db Syst Rev. 2011, 1-54. 2
13.
Anderson JE, Jorenby DE, Scott WJ, Fiore MC: Treating tobacco use and dependence: An evidence-based clinical practice guideline for tobacco cessation. Chest. 2002, 932-941. 121
14.
Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER, Heyman RB, Jaén CR, Kottke TE, Lando HA, Mecklenburg RE, Mullen PD, Nett LM, Robinson L, Stitzer ML, Tommasello AC, Villejo L, Wewers ME: Treating tobacco use and dependence. 2000, Rockville, MD: U.S. Department of Health and Human Services: Public Health Service
15.
West R, McNeill A, Raw M: Smoking cessation guidelines for health professionals: an update. Thorax. 2000, 987-999. 55
16.
Etter M, Mohr S, Qarin C, Etter JF: Stages of change in smokers with schizophrenia or schizoaffective disorder and in the general population. Schizophrenia Bull. 2004, 30 (2): 459-468.CrossRef
17.
Siru R, Hulse GK, Khan RJK, Tait RJ: Motivation to quit smoking among hospitalised individuals with and without mental health disorders. Aust NZ J Psychiat. 2010, 44: 640-647. 10.3109/00048671003627413.CrossRef
18.
Solty H, Crockford D, White WD, Currie S: Cigarette smoking, nicotine dependence, and motivation for smoking cessation in psychiatric inpatients. Can J Psychiat. 2009, 54 (1): 36-45.
19.
Banham L, Gilbody S: Smoking cessation in severe mental illness: what works?. Addiction. 2010, 105: 1176-1189. 10.1111/j.1360-0443.2010.02946.x.CrossRefPubMed
20.
el-Guebaly N, Cathcart J, Currie S, Brown D, Gloster S: Smoking cessation approaches for persons with mental illness or addictive disorders. Psychiat Serv. 2002, 53 (9): 1166-1171. 10.1176/appi.ps.53.9.1166.CrossRef
21.
Baker A, Richmond R, Haile M, Lewin TJ, Carr VJ, Taylor RL, Jansons S, Wilhelm K: A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder. Am J Psychiat. 2006, 163: 1934-1942. 10.1176/appi.ajp.163.11.1934.CrossRefPubMed
22.
McFall M, Saxon AJ, Malte CA, Chow B, Bailey S, Baker DG, Beckham JC, Boardman KD, Carmody TP, Joseph AM, Smith MW, Shih M-C, Lu Y, Holodniy M, Lavori PW: Integrating tobacco cessation into mental health care for posttraumatic stress disorder: A randomized controlled trial. JAMA. 2010, 304 (22): 2485-2493. 10.1001/jama.2010.1769.CrossRefPubMedPubMedCentral
23.
Hall SM, Tsoh JY, Prochaska JJ, Eisendrath S, Rossi JS, Redding CA, Rosen AB, Meisner M, Humfleet GL, Gorecki JA: Treatment for cigarette smoking among depressed mental health outpatients: A randomized clinical trial. Am J Public Health. 2006, 96 (10): 1808-1814. 10.2105/AJPH.2005.080382.CrossRefPubMedPubMedCentral
24.
Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC: A 12-week double-blind, placebo-controlled study of bupropion SR added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. J Clin Psychol Med S. 2007, 27 (4): 380-386.
25.
Campion J, Checinski K, Nurse J: Review of smoking cessation treatments for people with mental illness. Advances in Psychiatric Treatment. 2008, 14: 208-216. 10.1192/apt.bp.107.003483.CrossRef
26.
Freund M, Campbell E, Paul C, Sakrouge R, Lecathelinais C, Knight J, Wiggers J, Walsh RA, Jones T, Girgis A, Nagle A: Increasing hospital-wide delivery of smoking cessation care for nicotine-dependent in-patients: a multi-strategic intervention trial. Addiction. 2009, 104: 839-849. 10.1111/j.1360-0443.2009.02520.x.CrossRefPubMed
27.
Rigotti N, Munafo' M, Stead L: Interventions for smoking cessation in hospitalised patients (Review). Cochrane Db Syst Rev. 2007, 1-54. 3
28.
Wolfenden L, Campbell E, Wiggers J: Smoking cessation interventions for in-patients: a selective review with recommendations for hospital-based health professionals. Drug Alcohol Rev. 2003, 22: 437-452. 10.1080/09595230310001613967.CrossRefPubMed
29.
Duffy SA, Scholten RL, Karvonen-Gutierrez CA: The relation of tobacco use during hospitalization to post-discharge smoking cessation among US veterans. Prev Med. 2010, 50: 285-287. 10.1016/j.ypmed.2010.01.012.CrossRefPubMed
30.
New South Wales Department of Health: Guide for the management of nicotine dependent inpatients. 2002, Sydney (AUST): State Government of New South Wales
31.
Shmueli D, Fletcher L, Hall SE, Hall SM, Prochaska JJ: Changes in psychiatric patients' thoughts about quitting smoking during a smoke-free hospitalization. Nicotine &Tobacco Research. 2008, 10 (5): 875-881. 10.1080/14622200802027198.CrossRef
32.
Hall SM, Prochaska JJ: Treatment of smokers with co-occurring disorders: emphasis on integration in mental health and addiction treatment settings. Annu Rev Clin Psycho. 2009, 5: 409-431. 10.1146/annurev.clinpsy.032408.153614.CrossRef
33.
Prochaska JJ: Integrating tobacco treatment into mental health settings. JAMA. 2010, 304 (22): 2354-2356.CrossRef
34.
Johnson JL, Malchy LA, Ratner PA, Hossain S, Procyshyn RM, Bottorff JL, Groening M, Gibson P, Osborne M, Schultz A: Community mental healthcare providers' attitudes and practices related to smoking cessation interventions for people living with severe mental illness. Patient Educ Couns. 2009, 77: 289-295. 10.1016/j.pec.2009.02.013.CrossRefPubMed
35.
Price JH, Ambrosetti LM, Sidani JE, Price JA: Psychiatrists smoking cessation activities with Ohio community mental health center patients. Community Ment Hlt J. 2007, 43 (3): 251-266. 10.1007/s10597-006-9074-3.CrossRef
36.
Wye P, Bowman J, Wiggers J, Baker A, Carr V, Terry M, Knight J, Clancy R: An audit of the prevalence of recorded nicotine dependence treatment in an Australian psychiatric hospital. Aust NZ J Publ Heal. 2010, 34 (3): 298-303. 10.1111/j.1753-6405.2010.00530.x.CrossRef
37.
Jonas JM, Eagle J: Smoking patterns among patients discharged from a smoke-free inpatient unit. Hosp Community Psych. 1991, 42 (6): 636-638.
38.
Schulz KF, Altman DG, Moher D: CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010, 152 (11): 1-7.CrossRef
39.
Hedden SL, Woolson RF, Malcolm RJ: Randomization in substance abuse clinical trials. Substance Abuse Treatment, Prevention, and Policy. 2006, 1 (6): 17.-
40.
Lachin JM: Properties of simple randomization in clinical trials. Controlled Clin Trials. 1988, 9: 312-326. 10.1016/0197-2456(88)90046-3.CrossRefPubMed
41.
McChargue DE, Gulliver SB, Hitsman B: Would smokers with schizophrenia benefit from a more flexible approach to smoking treatment?. Addiction. 2002, 97: 785-793. 10.1046/j.1360-0443.2002.00064.x.CrossRefPubMed
42.
Hughes J, Keely J, Niaura R, Ossip-Klein D, Richmond R, Swan G: Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res. 2003, 5 (1): 13-25.CrossRefPubMed
43.
Stead LF, Lancaster T: Interventions to reduce harm from continued tobacco use (Review). Cochrane Db Syst Rev. 2007, 1-41. 3
44.
45.
46.
47.
48.
Lancaster T, Stead L: Self-help interventions for smoking cessation (Review). Cochrane Db Syst Rev. 2005, 1-90. 3
49.
Lai D, Cahill K, Qin Y, Tang J: Motivational interviewing for smoking cessation (Review). Cochrane Db Syst Rev. 2010, 1-37. 1
50.
Amodei N, Lamb RJ: The role of nicotine replacement therapy in early quitting success. Nicotine Tob Res. 2010, 12 (1): 1-10. 10.1093/ntr/ntp164.CrossRefPubMed
51.
Horst WD, Klein MW, Williams D, Werder SF: Extended use of nicotine replacement therapy to maintain smoking cessation in persons with schizophrenia. Neuropsychiatric Disease and Treatment. 2005, 1 (4): 349-355.
52.
Stead L, Perera R, Bullen C, Mant D, Lancaster T: Nicotine replacement therapy for smoking cessation (Review). Cochrane Db Syst Rev. 2008, 1-158. 1
53.
Bittoun R: A combination nicotine replacement therapy (NRT) algorithm for hard-to-treat smokers. Journal of Smoking Cessation. 2006, 1 (1): 3-6. 10.1375/jsc.1.1.3.CrossRef
54.
Heatherton T, Kozlowski L, Frecker R, Fagerström K: The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Brit J Addict. 1991, 86 (9): 1119-1127. 10.1111/j.1360-0443.1991.tb01879.x.CrossRef
55.
Stead L, Lancaster T: Group behaviour therapy programmes for smoking cessation (Review). Cochrane Db Syst Rev. 2005, 1-75. 2
56.
Hajek P: Current issues in behavioural and pharmacological approaches to smoking cessation. Addictive Behav. 1996, 21 (6): 699-707. 10.1016/0306-4603(96)00029-9.CrossRef
57.
Hajek P, Belcher M, Stapleton J: Enhancing the impact of groups: an evaluation of two group formats for smokers. Brit J Clin Psychol. 1985, 24 (4): 289-294. 10.1111/j.2044-8260.1985.tb00661.x.CrossRef
58.
Stead L, Perera R, Lancaster T: Telephone counselling for smoking cessation (Review). Cochrane Db Syst Rev. 2006, 1-93. 3
59.
Boys A, Marsden J, Stillwell G, Hatchings K, Griffiths P, Farrella M: Minimizing respondent attrition in longitudinal research: practical implications from a cohort study of adolescent drinking. J Adolescence. 2003, 26: 363-373. 10.1016/S0140-1971(03)00011-3.CrossRef
60.
Bruzzese J-M, Gallagher R, McCann-Doyle S, Reiss PT, Wijetunga NA: Effective methods to improve recruitment and retention in school-based substance use prevention studies. J School Health. 2009, 79 (9): 400-407. 10.1111/j.1746-1561.2009.00427.x.CrossRefPubMed
61.
Booker CL, Harding S, Benzeval M: A systematic review of the effect of retention methods in population-based cohort studies. BMC Public Health. 2011, 11: 249-261. 10.1186/1471-2458-11-249.CrossRefPubMedPubMedCentral
62.
Aveyard P, Wang D, Connock M, Fry-Smith A, Barton P, Moore D: Assessing the outcomes of prolonged cessation-induction and aid-to-cessation trials: floating prolonged abstinence. Nicotine Tob Res. 2009, 11 (5): 475-480. 10.1093/ntr/ntp035.CrossRefPubMedPubMedCentral
63.
West R, Hajek P, Stead L, Stapleton J: Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction. 2005, 100: 299-303. 10.1111/j.1360-0443.2004.00995.x.CrossRefPubMed
64.
Crittenden KS, Manfredi C, Lacey L, Warnecke R, Parsons J: Measuring readiness and motivation to quit smoking among women in public health clinics. Addictive Behaviors. 1994, 19 (5): 497-507. 10.1016/0306-4603(94)90005-1.CrossRefPubMed
65.
Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG: The alcohol use disorders identification test guidelines for use in primary care. 1990, Geneva: World Health Organization, 1-35.
66.
Kessler RC, Barker PR, Colpe LJ, Epstein JF, Gfroerer JC, Hiripi E, Howes MJ, Normand S-LT, Manderscheid RW, Walters EE, Zaslavsky AM: Screening for serious mental illness in the general population. Arch Gen Psychiat. 2003, 60: 184-189. 10.1001/archpsyc.60.2.184.CrossRefPubMed
67.
Vial R, Jones T, Ruffin R, Gilbert A: Smoking cessation program using nicotine patches linking hospital to the community. Journal of Pharmacy Practice and Research. 2003, 32: 57-62.CrossRef
68.
Williams J, Jones T: Smoking cessation post-discharge following nicotine replacement therapy use during an inpatient admission. Internal Med J. 2011, Accepted Article
Metadata
Title
A randomised controlled trial linking mental health inpatients to community smoking cessation supports: A study protocol
Authors
Emily AL Stockings
Jennifer A Bowman
John Wiggers
Amanda L Baker
Margarett Terry
Richard Clancy
Paula M Wye
Jenny Knight
Lyndell H Moore
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2011
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-11-570

Other articles of this Issue 1/2011

BMC Public Health 1/2011 Go to the issue

Study protocol

Detection of mild cognitive impairment in people older than 65 years of age and its relationship to cardiovascular risk factors (DECRIVAM)

Research article

Burden of traumatic spine fractures in Tehran, Iran

Research article

Health care seeking among detained undocumented migrants: a cross-sectional study

Research article

Prioritising public health: a qualitative study of decision making to reduce health inequalities

Research article

Mode shifting in school travel mode: examining the prevalence and correlates of active school transport in Ontario, Canada

Research article

Number and timing of antenatal HIV testing: Evidence from a community-based study in Northern Vietnam